The neuroprotective agent SR 57746A abrogates experimental autoimmune encephalomyelitis and impairs associated blood-brain barrier disruption: implications for multiple sclerosis treatment.

Source:http://linkedlifedata.com/resource/pubmed/id/10536012

Proc. Natl. Acad. Sci. U.S.A. 1999 Oct 26 96 22 12855-9

Download in:

View as

Triples

General Info

PMID
10536012